Susan Hasty, Publisher
Table of Contents . . . July 8th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
AIDS and HIV Pathogenesis - HIV targets virus-specific CD4 cells
Clinical Trials - Minority and HMO-insured patients poorly represented in HIV drug trials
AIDS and HIV Therapy - Line probe assay can predict treatment outcome
AIDS and HIV Therapy - Lopinavir can enhance safety, efficacy of antiretroviral regimens
Obstetrics - Study concludes benefits of anti-HIV therapy during pregnancy outweigh risks
AIDS Therapy - Researchers develop HIV fighter
AIDS Vaccine - The Immune Response Corp. releases results for new vaccine candidate
AIDS and HIV Pathogenesis - Mucosal antibodies offer no protection
Antiretroviral Therapy - ViroLogic launches viral fitness assay for HIV patient testing
Correction - AIDS Weekly May 27, 2002, Headline Error
Funding - International Red Cross: Food giant Nestle boosts AIDS fight with donation
Influenza - Clinicians should consider influenza A and B when diagnosing a febrile respiratory illness during the summer
Policy - African religious leaders meet to discuss AIDS crisis, insist that abstinence is best
Policy - Clinton urges Bush to come up with $2.4 billion annually to fight AIDS
Restructuring - Novirio becomes Idenix Pharmaceuticals, Inc.
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.